Table 2 Prevalences of the 11 outcomes.
Study | Prevalence within each study (%) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Standard deviation of area‐level prevalences within study (%) | |||||||||||
Wheeze | Asthma | Bronchitis | Phlegm | Nocturnal cough | Morning cough | Sensitivity to inhaled allergens | Hay fever | Itchy rash | Woken by wheeze | Allergy to pets | |
Russia | 13.40 | 1.88 | 14.72 | 7.15 | 11.35 | 6.44 | 1.21 | 4.36 | |||
2.6 | 1.1 | 3.7 | 1.7 | 2.7 | 2.4 | 1.0 | 1.2 | ||||
Austria | 13.55 | 8.59 | 10.42 | 5.30 | 12.78 | 5.24 | 8.17 | 5.81 | |||
2.1 | 3.5 | 2.1 | 1.4 | 2.5 | 2.1 | 2.1 | 1.6 | ||||
Switzerland | 10.37 | 8.98 | 18.25 | 21.54 | 11.90 | 13.73 | 10.15 | 13.29 | 4.64 | 4.56 | |
2.1 | 2.2 | 7.8 | 9.8 | 4.1 | 2.1 | 2.5 | 2.5 | 1.3 | 1.2 | ||
Netherlands | 9.54 | 8.14 | 7.92 | 9.54 | 21.58 | 15.22 | 7.19 | 22.26 | 4.93 | 9.30 | |
3.6 | 4.1 | 3.7 | 4.1 | 6.5 | 5.7 | 3.2 | 5.3 | 2.4 | 4.1 | ||
Italy | 6.72 | 9.00 | 12.43 | 5.53 | 15.73 | 10.92 | 7.81 | 14.16 | 1.82 | 1.82 | |
1.2 | 2.5 | 4.4 | 1.6 | 2.5 | 2.2 | 2.3 | 2.8 | 1.0 | 1.1 |
Gaps occur where outcomes were not measured by all studies.